{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-308899","form_type":"8-K","ticker":"DMRA","cik":"0001800315","company_name":"Damora Therapeutics, Inc.","filed_at":"2026-07-20T20:00:14+00:00","discovered_at":"2026-07-20T20:01:00.509898+00:00","generated_at":"2026-07-20T20:01:59.969130+00:00","sec_items":["1.01","3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Damora Therapeutics completes redomestication from Delaware to Cayman Islands","bullets":["Redomestication effective July 16, 2026; each common share converted 1:1 into ordinary shares of Cayman company.","New CUSIP G2646Y104; ordinary shares continue trading on Nasdaq under symbol DMRA as of July 20, 2026.","No change in business, management, obligations, assets, or liabilities; company remains a U.S. corporation for tax purposes.","Stockholders approved the redomestication at a special meeting on February 9, 2026.","Company also entered into indemnification agreements with directors and executive officers."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-308899","json":"https://secwatch.observer/filing/0001193125-26-308899.json","markdown":"https://secwatch.observer/filing/0001193125-26-308899.md","text":"https://secwatch.observer/filing/0001193125-26-308899.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526308899/0001193125-26-308899-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800315/000119312526308899/dmra-20260716.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-20T20:01:59.969130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}